Abstract Background IgG anti-Domain I (anti-DI) β2 Glycoprotein I (β2GPI) antibodies are
associated to thrombotic risk in antiphospholipid syndrome (APS), but their detection is …

Background Classification of the antiphospholipid syndrome (APS) relies predominantly on
detecting antiphospholipid antibodies (aPLs). Antibodies against a domain I (DI) epitope of …

Background There seems to be a clear correlation between antibodies against domain I
(anti-DI) of β2Glycoprotein I and severe clinical profiles in antiphospholipid syndrome (APS) …

Introduction Antibodies to the domain 1 of beta 2 glycoprotein I (β2GPI–D1) have been
suggested as a risk marker for thrombosis in patients with the antiphospholipid syndrome …

Background Antiphospholipid syndrome (APS) is characterized by the presence of
circulating antiphospholipid antibodies (aPL) in patients with thrombosis and/or pregnancy …

To investigate the prevalence, significance, and specificity of IgG isotype anti-β2-
Glycoprotein I antibodies (a-β2-GPI) in antiphospholipid syndrome (APS), we developed an …

Background: Primary antiphospholipid syndrome (PAPS) is an autoimmune disease
characterized by thrombosis and/or pregnancy morbidity as well as blood antiphospholipid …

Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of
antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a …

Background Antiphospholipid syndrome (APS) is characterized by the presence circulating
antiphospholipid (aPL) antibodies in patients with thrombosis or pregnancy morbidity …

Antibodies against β2-glycoprotein I (anti-β2GPI) are one of the hallmarks of the
antiphospholipid syndrome (APS). However, they are heterogenic regarding their epitope …